...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Aneuploidy detection in mixed DNA samples by methylation-sensitive amplification and microarray analysis.
【24h】

Aneuploidy detection in mixed DNA samples by methylation-sensitive amplification and microarray analysis.

机译:通过甲基化敏感扩增和微阵列分析检测混合DNA样品中的非整倍性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Cell-free fetal nucleic acid, believed to be derived from the placenta/trophoblast, is present in the plasma of pregnant women; however, its use for predictive genetic testing has been severely limited because the circulating fetal DNA is present in a small quantity and mixed with a much larger quantity of maternal DNA. Methods for detecting fetal aneuploidy from the cell-free fetal DNA in plasma are highly sought after, but proposed methods must take into account the small quantity and highly contaminated nature of the available fetal DNA. METHODS: We developed a method for methylation-sensitive amplification of DNA suitable for use with small (approximately 1 ng) samples. We used this method in conjunction with 2-color microarray analysis with a custom-made array to investigate whether relative amplification, and hence relative methylation, could be evaluated for a large number of genomic loci. RESULTS: Microarray assessment of genomic methylation accurately predicted the degree of methylation measured with bisulfite-conversion PCR and confirmed that DNA from first-trimester trophoblast was generally hypomethylated compared with whole-blood DNA. With a series of 3 samples in which 1 ng of DNA from a trisomic first trimester placenta was mixed with 9 ng of chromosomally normal peripheral blood DNA, we observed that the microarray signal associated with the trisomic chromosome was significantly different from that of the other chromosomes (P < 0.001). CONCLUSIONS: This method has potential to be used for noninvasive detection of fetal aneuploidy.
机译:背景:孕妇血浆中存在无细胞胎儿核酸,据信源自胎盘/滋养细胞。然而,由于循环中的胎儿DNA的存在量很少,并且与大量的母体DNA混合在一起,因此其在预测基因测试中的应用受到了严格的限制。寻求从血浆中无细胞的胎儿DNA检测胎儿非整倍性的方法,但是提出的方法必须考虑到可用的胎儿DNA的少量和高度污染的性质。方法:我们开发了一种适用于小样本(约1 ng)样品的DNA甲基化敏感性扩增方法。我们将这种方法与定制阵列的2色微阵列分析结合使用,以研究是否可以针对大量的基因组位点评估相对扩增,从而评估相对甲基化。结果:基因组甲基化的微阵列评估可准确预测使用亚硫酸氢盐转化PCR测得的甲基化程度,并证实与全血DNA相比,早孕滋养细胞的DNA通常被低甲基化。在一系列3个样本中,其中将1 ng来自三体性早孕胎盘的DNA与9 ng染色体正常外周血DNA混合,我们观察到与三体性染色体相关的微阵列信号与其他染色体的显着不同(P <0.001)。结论:该方法有潜力用于非侵入性检测胎儿非整倍性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号